HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Maes Selected Research

Desipramine (Pertofrane)

1/2018Stimulatory effect of desipramine on lung metastases of adenocarcinoma MADB 106 in stress highly-sensitive and stress non-reactive rats.
1/2013Inhibitory effect of antidepressants on B16F10 melanoma tumor growth.
12/2011Stimulatory effect of antidepressant drug pretreatment on progression of B16F10 melanoma in high-active male and female C57BL/6J mice.
11/2009Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10 melanoma in male C57BL/6 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Maes Research Topics

Disease

71Schizophrenia (Dementia Praecox)
09/2022 - 04/2002
66Inflammation (Inflammations)
06/2022 - 09/2002
42Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
04/2022 - 10/2005
34Fatigue
04/2022 - 10/2006
31Mood Disorders (Mood Disorder)
08/2022 - 11/2003
31Bipolar Disorder (Manic Depressive Psychosis)
06/2022 - 09/2002
29Psychotic Disorders (Schizoaffective Disorder)
10/2022 - 01/2004
29Major Depressive Disorder (Major Depressive Disorders)
08/2022 - 01/2014
25Depressive Disorder (Melancholia)
04/2021 - 02/2005
20Infections
01/2022 - 10/2003
15Mental Disorders (Mental Disorder)
08/2022 - 12/2002
15Cognitive Dysfunction
01/2022 - 02/2012
15Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 12/2012
14Medically Unexplained Symptoms
04/2022 - 02/2012
14Multiple Sclerosis
05/2020 - 01/2011
13Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 01/2011
12Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2014
11Pain (Aches)
01/2022 - 10/2006
11Neuroinflammatory Diseases
01/2022 - 11/2012
10Neoplasms (Cancer)
01/2022 - 02/2002
10Insulin Resistance
01/2022 - 11/2014
10Autistic Disorder (Autism)
01/2021 - 01/2002
10Parkinson Disease (Parkinson's Disease)
01/2021 - 12/2013
9COVID-19
07/2022 - 05/2020
9Fibromyalgia (Fibrositis)
01/2022 - 12/2013
9Tobacco Use Disorder (Nicotine Dependence)
11/2021 - 06/2014
8Necrosis
01/2021 - 12/2002
7Autism Spectrum Disorder
01/2022 - 01/2018
7Anxiety Disorders (Anxiety Disorder)
11/2021 - 12/2012
7Obesity
12/2020 - 01/2011
6Treatment-Resistant Depressive Disorder
04/2022 - 02/2004
6Wounds and Injuries (Trauma)
01/2022 - 08/2010
6Dysbiosis
02/2020 - 01/2017
6Premenstrual Syndrome (Premenstrual Tension)
01/2020 - 12/2016
6Postpartum Depression (Post-Natal Depression)
02/2018 - 12/2007
6Disease Progression
12/2017 - 03/2016
5Iron Overload
06/2022 - 01/2018
5Stroke (Strokes)
02/2022 - 01/2011
5Mania (Manias)
01/2021 - 06/2002

Drug/Important Bio-Agent (IBA)

69Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2012
57CytokinesIBA
06/2022 - 01/2002
54Tryptophan (L-Tryptophan)FDA Link
09/2022 - 09/2002
37Immunoglobulin M (IgM)IBA
02/2022 - 10/2003
32AntioxidantsIBA
01/2022 - 10/2006
29Immunoglobulin A (IgA)IBA
07/2021 - 04/2007
28Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2002
24Pharmaceutical PreparationsIBA
03/2022 - 01/2004
24Antidepressive Agents (Antidepressants)IBA
04/2021 - 12/2002
20Biological ProductsIBA
01/2021 - 01/2004
19Interleukin-6 (Interleukin 6)IBA
03/2022 - 12/2002
19Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 12/2002
17Interleukin-10 (Interleukin 10)IBA
03/2022 - 12/2002
16Aryldialkylphosphatase (Paraoxonase)IBA
05/2022 - 04/2014
16Malondialdehyde (Propanedial)IBA
02/2022 - 04/2011
15ZincIBA
12/2022 - 12/2005
15InterleukinsIBA
03/2022 - 02/2005
15Serotonin (5 Hydroxytryptamine)IBA
01/2022 - 03/2005
14LipidsIBA
03/2021 - 10/2006
12C-Reactive ProteinIBA
03/2022 - 04/2011
10KynurenineIBA
09/2022 - 09/2002
10Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 04/2011
10Advanced Oxidation Protein Products (AOPP)IBA
11/2021 - 11/2017
10Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2020 - 02/2012
10AntibodiesIBA
10/2019 - 03/2003
9CalciumIBA
12/2022 - 03/2017
9EnzymesIBA
09/2022 - 12/2007
9Polytetrafluoroethylene (Teflon)FDA Link
10/2021 - 10/2014
9HaptoglobinsIBA
01/2021 - 03/2005
9HDL CholesterolIBA
01/2021 - 04/2014
9Glutathione (Reduced Glutathione)IBA
01/2021 - 04/2011
9Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
09/2020 - 12/2005
8Opioid Analgesics (Opioids)IBA
12/2022 - 01/2019
8InterferonsIBA
01/2022 - 02/2005
8Antipsychotic Agents (Antipsychotics)IBA
10/2021 - 04/2002
8Uric Acid (Urate)IBA
10/2020 - 07/2015
8EpitopesIBA
02/2020 - 02/2012
8Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 05/2004
8DNA (Deoxyribonucleic Acid)IBA
04/2019 - 01/2009
8NeopterinIBA
12/2012 - 07/2003
7MagnesiumIBA
12/2022 - 12/2012
7AlbuminsIBA
04/2022 - 10/2016
7ChemokinesIBA
03/2021 - 05/2018
7HDL LipoproteinsIBA
01/2021 - 04/2014
7MelatoninIBA
03/2017 - 06/2012
6Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2022 - 04/2011
6Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2022 - 04/2011
6Neurotransmitter Agents (Neurotransmitter)IBA
01/2022 - 02/2005
6Messenger RNA (mRNA)IBA
01/2022 - 05/2012
6Glucose (Dextrose)FDA LinkGeneric
12/2021 - 11/2014
6IronIBA
05/2021 - 01/2017
6Interleukin-17 (Interleukin 17)IBA
04/2021 - 10/2015
6oxidized low density lipoproteinIBA
01/2021 - 09/2010
6Interleukin-4 (Interleukin 4)IBA
05/2020 - 11/2014
6Hydrocortisone (Cortisol)FDA LinkGeneric
01/2020 - 10/2004
6coenzyme Q10 (CoQ10)IBA
12/2013 - 01/2009
5CopperIBA
12/2022 - 03/2021
5EndorphinsIBA
12/2022 - 11/2019
5CateninsIBA
04/2022 - 08/2019
5CholesterolIBA
01/2021 - 05/2004

Therapy/Procedure

11Therapeutics
04/2022 - 01/2004